Northpond Ventures is a multi-billion-dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has consistently been named one of the most active lead life science investors in venture industry rankings. It is deeply engaged in the academic ecosystem, having founded The Laboratory for Bioengineering Research and Innovation at the Wyss Institute at Harvard University; launched the MIT-Northpond Program – Advancing Life Science & Engineering Innovation; launched the Northpond Laboratories — Program for Research and Innovation at Stanford Medicine; and sponsored a prize for women entrepreneurs at MIT. It has led or co-led over 60 financings over the past several years and sits on the board of the vast majority of these businesses. Learn more at npv.vc.

Nanoview Biosciences

Vigil Neuroscience

908 Devices

Intabio

IsoPlexis

Personal Genome Diagnostics

Current Health

Candel Therapeutics

Codex DNA

Dice Therapeutics

Northpond Ventures

NPV.VC is a venture capital firm that specializes in investing in early-stage technology startups. The firm provides capital, mentorship, and strategic support to help startups scale and succeed in the market. They focus on innovative solutions and disruptive technologies across various sectors.

NPV.VC

VC:NPV

NPV.VC

Filings Not Available